Interaction between gemcitabine and topotecan in human non-small-cell lung cancer cells: effects on cell survival, cell cycle and pharmacogenetic profile View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2005-02

AUTHORS

E Giovannetti, F Basolo, M Del Tacca, M Deri, R Danesi, S Barachini, V Mey

ABSTRACT

The pyrimidine analogue gemcitabine is an established effective agent in the treatment of non-small-cell lung cancer (NSCLC). The present study investigates whether gemcitabine would be synergistic with the topoisomerase I inhibitor topotecan against the NSCLC A549 and Calu-6 cells. Cells were treated with gemcitabine and topotecan for 1 h and the type of drug interaction was assessed using the combination index (CI). Cell cycle alterations were analysed by flow cytometry, while apoptosis was examined by the occurrence of DNA internucleosomal fragmentation, nuclear condensation and caspase-3 activation. Moreover, the possible involvement of the PI3K-Akt signalling pathway was investigated by the measurement of Akt phosphorylation. Finally, quantitative, real-time PCR (QRT-PCR) was used to study modulation of the gemcitabine-activating enzyme deoxycytidine kinase (dCK) and the cellular target enzyme ribonucleotide reductase (RR). In results, it was found that simultaneous and sequential topotecan --> gemcitabine treatments were synergistic, while the reverse sequence was antagonistic in both cell lines. DNA fragmentation, nuclear condensation and enhanced caspase-3 activity demonstrated that the drug combination markedly increased apoptosis in comparison with either single agent, while cell cycle analysis showed that topotecan increased cells in S phase. Furthermore, topotecan treatment significantly decreased the amount of the activated form of Akt, and enhanced the expression of dCK (+155.0 and +115.3% in A549 and Calu-6 cells, respectively), potentially facilitating gemcitabine activity. In conclusion, these results indicate that the combination of gemcitabine and topotecan displays schedule-dependent activity in vitro against NSCLC cells. The gemcitabine --> topotecan sequence is antagonistic while drug synergism is obtained with the simultaneous and the sequential topotecan --> gemcitabine combinations, which are associated with induction of decreased Akt phosphorylation and increased dCK expression. More... »

PAGES

681

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/sj.bjc.6602382

DOI

http://dx.doi.org/10.1038/sj.bjc.6602382

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1042132505

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/15700043


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0601", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Biochemistry and Cell Biology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/06", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Biological Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antimetabolites, Antineoplastic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Apoptosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma, Non-Small-Cell Lung", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Caspase 3", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Caspases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Cycle", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Line, Tumor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "DNA Fragmentation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Deoxycytidine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Deoxycytidine Kinase", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Synergism", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Enzyme Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gene Expression Regulation, Enzymologic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gene Expression Regulation, Neoplastic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lung Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Phosphorylation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Polymerase Chain Reaction", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Protein-Serine-Threonine Kinases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Proto-Oncogene Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Proto-Oncogene Proteins c-akt", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Topoisomerase I Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Topotecan", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of Pisa", 
          "id": "https://www.grid.ac/institutes/grid.5395.a", 
          "name": [
            "Division of Pharmacology and Chemotherapy, Department of Oncology, Transplants and Advanced Technologies in Medicine, University of Pisa, 55, Via Roma, 56126 Pisa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Giovannetti", 
        "givenName": "E", 
        "id": "sg:person.0577505063.56", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0577505063.56"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Pisa", 
          "id": "https://www.grid.ac/institutes/grid.5395.a", 
          "name": [
            "Division of Pathological Anatomy and Histology, Department of Oncology, Transplants and Advanced Technologies in Medicine, University of Pisa, Pisa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Basolo", 
        "givenName": "F", 
        "id": "sg:person.01043347623.83", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01043347623.83"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Pisa", 
          "id": "https://www.grid.ac/institutes/grid.5395.a", 
          "name": [
            "Division of Pharmacology and Chemotherapy, Department of Oncology, Transplants and Advanced Technologies in Medicine, University of Pisa, 55, Via Roma, 56126 Pisa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Del Tacca", 
        "givenName": "M", 
        "id": "sg:person.0101712630.89", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0101712630.89"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Pisa", 
          "id": "https://www.grid.ac/institutes/grid.5395.a", 
          "name": [
            "Division of Pharmacology and Chemotherapy, Department of Oncology, Transplants and Advanced Technologies in Medicine, University of Pisa, 55, Via Roma, 56126 Pisa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Deri", 
        "givenName": "M", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Pisa", 
          "id": "https://www.grid.ac/institutes/grid.5395.a", 
          "name": [
            "Division of Pharmacology and Chemotherapy, Department of Oncology, Transplants and Advanced Technologies in Medicine, University of Pisa, 55, Via Roma, 56126 Pisa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Danesi", 
        "givenName": "R", 
        "id": "sg:person.0704167507.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0704167507.01"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Pisa", 
          "id": "https://www.grid.ac/institutes/grid.5395.a", 
          "name": [
            "Division of Pharmacology and Chemotherapy, Department of Oncology, Transplants and Advanced Technologies in Medicine, University of Pisa, 55, Via Roma, 56126 Pisa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Barachini", 
        "givenName": "S", 
        "id": "sg:person.01324114222.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01324114222.11"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Pisa", 
          "id": "https://www.grid.ac/institutes/grid.5395.a", 
          "name": [
            "Division of Pharmacology and Chemotherapy, Department of Oncology, Transplants and Advanced Technologies in Medicine, University of Pisa, 55, Via Roma, 56126 Pisa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mey", 
        "givenName": "V", 
        "id": "sg:person.01003441425.29", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01003441425.29"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s002800000183", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000135772", 
          "https://doi.org/10.1007/s002800000183"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6690452", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004051184", 
          "https://doi.org/10.1038/sj.bjc.6690452"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6690452", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004051184", 
          "https://doi.org/10.1038/sj.bjc.6690452"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/86.20.1517", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007437694"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00003495-199754030-00009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011803547", 
          "https://doi.org/10.2165/00003495-199754030-00009"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1159/000011923", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013350898"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.10806", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014472277"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ijc.10166", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015732358"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1074/jbc.274.7.4335", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016160331"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0169-5002(03)90522-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016902652"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/(sici)1097-0215(20000515)86:4<570::aid-ijc20>3.0.co;2-t", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018134417"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa031644", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018253348"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0169-5002(02)00502-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018310648"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0169-5002(02)00502-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018310648"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0006-2952(98)00318-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018647627"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0092-8674(00)81005-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021076197"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/0008-5472.can-03-3363", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022118795"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1006325929424", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022329366", 
          "https://doi.org/10.1023/a:1006325929424"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0006-2952(98)00316-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028767356"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s002800000273", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031302839", 
          "https://doi.org/10.1007/s002800000273"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0959-8049(98)00425-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032352964"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0959-8049(99)00223-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035253746"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-03-0520", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036865675"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1081/cnv-120022363", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037383721"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1368-7646(02)00002-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039632637"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.cdd.4400336", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042512023", 
          "https://doi.org/10.1038/sj.cdd.4400336"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.cdd.4400336", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042512023", 
          "https://doi.org/10.1038/sj.cdd.4400336"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0304-4165(99)00209-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045475119"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/88.11.734", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046560733"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0169-5002(03)00136-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052265808"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0169-5002(03)00136-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052265808"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/bi9729357", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1055215192"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/bi9729357", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1055215192"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.311.7010.899", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062773493"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.311.7010.899", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062773493"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074273055", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074520995", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074708162", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074712924", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074778809", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074859791", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3727/096504001108747819", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074951474"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1075104035", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082401402", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082893566", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1083077109", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1083077109", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/ajhp/54.2.162", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083077109"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/ajhp/54.2.162", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083077109"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/ajhp/54.2.162", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083077109"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1083269732", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1083347691", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2005-02", 
    "datePublishedReg": "2005-02-01", 
    "description": "The pyrimidine analogue gemcitabine is an established effective agent in the treatment of non-small-cell lung cancer (NSCLC). The present study investigates whether gemcitabine would be synergistic with the topoisomerase I inhibitor topotecan against the NSCLC A549 and Calu-6 cells. Cells were treated with gemcitabine and topotecan for 1 h and the type of drug interaction was assessed using the combination index (CI). Cell cycle alterations were analysed by flow cytometry, while apoptosis was examined by the occurrence of DNA internucleosomal fragmentation, nuclear condensation and caspase-3 activation. Moreover, the possible involvement of the PI3K-Akt signalling pathway was investigated by the measurement of Akt phosphorylation. Finally, quantitative, real-time PCR (QRT-PCR) was used to study modulation of the gemcitabine-activating enzyme deoxycytidine kinase (dCK) and the cellular target enzyme ribonucleotide reductase (RR). In results, it was found that simultaneous and sequential topotecan --> gemcitabine treatments were synergistic, while the reverse sequence was antagonistic in both cell lines. DNA fragmentation, nuclear condensation and enhanced caspase-3 activity demonstrated that the drug combination markedly increased apoptosis in comparison with either single agent, while cell cycle analysis showed that topotecan increased cells in S phase. Furthermore, topotecan treatment significantly decreased the amount of the activated form of Akt, and enhanced the expression of dCK (+155.0 and +115.3% in A549 and Calu-6 cells, respectively), potentially facilitating gemcitabine activity. In conclusion, these results indicate that the combination of gemcitabine and topotecan displays schedule-dependent activity in vitro against NSCLC cells. The gemcitabine --> topotecan sequence is antagonistic while drug synergism is obtained with the simultaneous and the sequential topotecan --> gemcitabine combinations, which are associated with induction of decreased Akt phosphorylation and increased dCK expression.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/sj.bjc.6602382", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1017082", 
        "issn": [
          "0007-0920", 
          "1532-1827"
        ], 
        "name": "British Journal of Cancer", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "92"
      }
    ], 
    "name": "Interaction between gemcitabine and topotecan in human non-small-cell lung cancer cells: effects on cell survival, cell cycle and pharmacogenetic profile", 
    "pagination": "681", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "c8b2a0633725f3a8e00edd3d1d149046fa818c82961f5a97907499e0e70f1e55"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "15700043"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "0370635"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/sj.bjc.6602382"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1042132505"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/sj.bjc.6602382", 
      "https://app.dimensions.ai/details/publication/pub.1042132505"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T11:56", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000359_0000000359/records_29216_00000002.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://www.nature.com/articles/6602382"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6602382'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6602382'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6602382'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6602382'


 

This table displays all metadata directly associated to this object as RDF triples.

330 TRIPLES      21 PREDICATES      96 URIs      45 LITERALS      33 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/sj.bjc.6602382 schema:about N0cd821e7dde44268a161676c6d68c93d
2 N126c5b018bae4caa9aad5043405b9f4d
3 N2a56d2a8701e4d05b1c245a4ce78694d
4 N32e14067ad4e43c6860dbd90f63b44c3
5 N3ad488ca82914eb585320302e0784455
6 N4d71e318e7d34f3f8ba3e412872b3a25
7 N537d602bb90e42e49c35b6e0419afb67
8 N5767ae1702db4010b7701cee98b32d62
9 N5a35857cd0d24c48b4de8f728aa7f4dd
10 N5d94f39582d04f2cab2c662428fdf503
11 N6dd09b4c830a4cf29e3e604cbd014ad6
12 N82ec50e41cfe400cac412d5e45e2ed47
13 N847ff4aeb8b548ed8161f42151343da4
14 N85cda43b04984bf4b7d4c0c5980fb632
15 N8ce57266b139408a8270b6a7e5c32bfe
16 N9704d508b2574ae0bade1244cd31e459
17 N9d55befbdf8443229e720ec2736c007b
18 Nb6d0c3a5e390442480c031f78598d2f4
19 Nc77df353bb2a432e80399f32a6f19a9c
20 Nd43b82973f014f8e98d0f8b4fab681f9
21 Ne31d1fbde9184fb98a517c8adf97a53d
22 Nf00b9452bace4338801d6584e7e50ac8
23 Nf11a68ab250e4255b53c6dd7b8a6c5d6
24 Nf98771973d5c496f886c50b7a83f6326
25 anzsrc-for:06
26 anzsrc-for:0601
27 schema:author Nc473b311b63740388dfced002542aca2
28 schema:citation sg:pub.10.1007/s002800000183
29 sg:pub.10.1007/s002800000273
30 sg:pub.10.1023/a:1006325929424
31 sg:pub.10.1038/sj.bjc.6690452
32 sg:pub.10.1038/sj.cdd.4400336
33 sg:pub.10.2165/00003495-199754030-00009
34 https://app.dimensions.ai/details/publication/pub.1074273055
35 https://app.dimensions.ai/details/publication/pub.1074520995
36 https://app.dimensions.ai/details/publication/pub.1074708162
37 https://app.dimensions.ai/details/publication/pub.1074712924
38 https://app.dimensions.ai/details/publication/pub.1074778809
39 https://app.dimensions.ai/details/publication/pub.1074859791
40 https://app.dimensions.ai/details/publication/pub.1075104035
41 https://app.dimensions.ai/details/publication/pub.1082401402
42 https://app.dimensions.ai/details/publication/pub.1082893566
43 https://app.dimensions.ai/details/publication/pub.1083077109
44 https://app.dimensions.ai/details/publication/pub.1083269732
45 https://app.dimensions.ai/details/publication/pub.1083347691
46 https://doi.org/10.1002/(sici)1097-0215(20000515)86:4<570::aid-ijc20>3.0.co;2-t
47 https://doi.org/10.1002/cncr.10806
48 https://doi.org/10.1002/ijc.10166
49 https://doi.org/10.1016/s0006-2952(98)00316-5
50 https://doi.org/10.1016/s0006-2952(98)00318-9
51 https://doi.org/10.1016/s0092-8674(00)81005-3
52 https://doi.org/10.1016/s0169-5002(02)00502-0
53 https://doi.org/10.1016/s0169-5002(03)00136-3
54 https://doi.org/10.1016/s0169-5002(03)90522-8
55 https://doi.org/10.1016/s0304-4165(99)00209-3
56 https://doi.org/10.1016/s0959-8049(98)00425-0
57 https://doi.org/10.1016/s0959-8049(99)00223-3
58 https://doi.org/10.1016/s1368-7646(02)00002-x
59 https://doi.org/10.1021/bi9729357
60 https://doi.org/10.1056/nejmoa031644
61 https://doi.org/10.1074/jbc.274.7.4335
62 https://doi.org/10.1081/cnv-120022363
63 https://doi.org/10.1093/ajhp/54.2.162
64 https://doi.org/10.1093/jnci/86.20.1517
65 https://doi.org/10.1093/jnci/88.11.734
66 https://doi.org/10.1136/bmj.311.7010.899
67 https://doi.org/10.1158/0008-5472.can-03-3363
68 https://doi.org/10.1158/1078-0432.ccr-03-0520
69 https://doi.org/10.1159/000011923
70 https://doi.org/10.3727/096504001108747819
71 schema:datePublished 2005-02
72 schema:datePublishedReg 2005-02-01
73 schema:description The pyrimidine analogue gemcitabine is an established effective agent in the treatment of non-small-cell lung cancer (NSCLC). The present study investigates whether gemcitabine would be synergistic with the topoisomerase I inhibitor topotecan against the NSCLC A549 and Calu-6 cells. Cells were treated with gemcitabine and topotecan for 1 h and the type of drug interaction was assessed using the combination index (CI). Cell cycle alterations were analysed by flow cytometry, while apoptosis was examined by the occurrence of DNA internucleosomal fragmentation, nuclear condensation and caspase-3 activation. Moreover, the possible involvement of the PI3K-Akt signalling pathway was investigated by the measurement of Akt phosphorylation. Finally, quantitative, real-time PCR (QRT-PCR) was used to study modulation of the gemcitabine-activating enzyme deoxycytidine kinase (dCK) and the cellular target enzyme ribonucleotide reductase (RR). In results, it was found that simultaneous and sequential topotecan --> gemcitabine treatments were synergistic, while the reverse sequence was antagonistic in both cell lines. DNA fragmentation, nuclear condensation and enhanced caspase-3 activity demonstrated that the drug combination markedly increased apoptosis in comparison with either single agent, while cell cycle analysis showed that topotecan increased cells in S phase. Furthermore, topotecan treatment significantly decreased the amount of the activated form of Akt, and enhanced the expression of dCK (+155.0 and +115.3% in A549 and Calu-6 cells, respectively), potentially facilitating gemcitabine activity. In conclusion, these results indicate that the combination of gemcitabine and topotecan displays schedule-dependent activity in vitro against NSCLC cells. The gemcitabine --> topotecan sequence is antagonistic while drug synergism is obtained with the simultaneous and the sequential topotecan --> gemcitabine combinations, which are associated with induction of decreased Akt phosphorylation and increased dCK expression.
74 schema:genre research_article
75 schema:inLanguage en
76 schema:isAccessibleForFree true
77 schema:isPartOf Nbdc16e8cd9f14bcc87ef3c8e37c46047
78 Nd1cd6d257eb94d7381abbe74b070d411
79 sg:journal.1017082
80 schema:name Interaction between gemcitabine and topotecan in human non-small-cell lung cancer cells: effects on cell survival, cell cycle and pharmacogenetic profile
81 schema:pagination 681
82 schema:productId N65fad5aa67d649059fedda2ad3fc8cf5
83 N74d794f07c3a438ab8ba189fb518401e
84 N8a521bdc1fe247da953966dae25b588d
85 Ne996f74b851746d89c64abcede679406
86 Necea93ead5104c8090d2a91f94e5e12b
87 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042132505
88 https://doi.org/10.1038/sj.bjc.6602382
89 schema:sdDatePublished 2019-04-11T11:56
90 schema:sdLicense https://scigraph.springernature.com/explorer/license/
91 schema:sdPublisher Nabb9785a69f44597968cdb179a104951
92 schema:url https://www.nature.com/articles/6602382
93 sgo:license sg:explorer/license/
94 sgo:sdDataset articles
95 rdf:type schema:ScholarlyArticle
96 N0cd821e7dde44268a161676c6d68c93d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
97 schema:name Topotecan
98 rdf:type schema:DefinedTerm
99 N126c5b018bae4caa9aad5043405b9f4d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
100 schema:name Gene Expression Regulation, Enzymologic
101 rdf:type schema:DefinedTerm
102 N2a56d2a8701e4d05b1c245a4ce78694d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Humans
104 rdf:type schema:DefinedTerm
105 N32e14067ad4e43c6860dbd90f63b44c3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Antimetabolites, Antineoplastic
107 rdf:type schema:DefinedTerm
108 N34edab287ec3495c9126cd8895daf234 rdf:first sg:person.01003441425.29
109 rdf:rest rdf:nil
110 N36d856773d2b4564a0dbd7fd7bfcbc83 rdf:first Na7dba37a1fe4495eb40e9a5123359a07
111 rdf:rest N52b6741e37e142ea82534294bdb6d963
112 N38977942ab4a4e6a95a8add04ee29a54 rdf:first sg:person.01324114222.11
113 rdf:rest N34edab287ec3495c9126cd8895daf234
114 N3ad488ca82914eb585320302e0784455 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Caspase 3
116 rdf:type schema:DefinedTerm
117 N4d71e318e7d34f3f8ba3e412872b3a25 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Enzyme Inhibitors
119 rdf:type schema:DefinedTerm
120 N52b6741e37e142ea82534294bdb6d963 rdf:first sg:person.0704167507.01
121 rdf:rest N38977942ab4a4e6a95a8add04ee29a54
122 N537d602bb90e42e49c35b6e0419afb67 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Phosphorylation
124 rdf:type schema:DefinedTerm
125 N5767ae1702db4010b7701cee98b32d62 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Caspases
127 rdf:type schema:DefinedTerm
128 N5a35857cd0d24c48b4de8f728aa7f4dd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Apoptosis
130 rdf:type schema:DefinedTerm
131 N5d94f39582d04f2cab2c662428fdf503 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Lung Neoplasms
133 rdf:type schema:DefinedTerm
134 N65fad5aa67d649059fedda2ad3fc8cf5 schema:name nlm_unique_id
135 schema:value 0370635
136 rdf:type schema:PropertyValue
137 N6b8de55b36ff4acdb54a038841a78926 rdf:first sg:person.0101712630.89
138 rdf:rest N36d856773d2b4564a0dbd7fd7bfcbc83
139 N6dd09b4c830a4cf29e3e604cbd014ad6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Polymerase Chain Reaction
141 rdf:type schema:DefinedTerm
142 N74d794f07c3a438ab8ba189fb518401e schema:name dimensions_id
143 schema:value pub.1042132505
144 rdf:type schema:PropertyValue
145 N82ec50e41cfe400cac412d5e45e2ed47 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Drug Synergism
147 rdf:type schema:DefinedTerm
148 N847ff4aeb8b548ed8161f42151343da4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Gene Expression Regulation, Neoplastic
150 rdf:type schema:DefinedTerm
151 N85cda43b04984bf4b7d4c0c5980fb632 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Antineoplastic Combined Chemotherapy Protocols
153 rdf:type schema:DefinedTerm
154 N8a521bdc1fe247da953966dae25b588d schema:name readcube_id
155 schema:value c8b2a0633725f3a8e00edd3d1d149046fa818c82961f5a97907499e0e70f1e55
156 rdf:type schema:PropertyValue
157 N8ce57266b139408a8270b6a7e5c32bfe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Proto-Oncogene Proteins c-akt
159 rdf:type schema:DefinedTerm
160 N9704d508b2574ae0bade1244cd31e459 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Deoxycytidine
162 rdf:type schema:DefinedTerm
163 N9d55befbdf8443229e720ec2736c007b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Topoisomerase I Inhibitors
165 rdf:type schema:DefinedTerm
166 Na7dba37a1fe4495eb40e9a5123359a07 schema:affiliation https://www.grid.ac/institutes/grid.5395.a
167 schema:familyName Deri
168 schema:givenName M
169 rdf:type schema:Person
170 Nabb9785a69f44597968cdb179a104951 schema:name Springer Nature - SN SciGraph project
171 rdf:type schema:Organization
172 Nb6d0c3a5e390442480c031f78598d2f4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Deoxycytidine Kinase
174 rdf:type schema:DefinedTerm
175 Nbdc16e8cd9f14bcc87ef3c8e37c46047 schema:issueNumber 4
176 rdf:type schema:PublicationIssue
177 Nc473b311b63740388dfced002542aca2 rdf:first sg:person.0577505063.56
178 rdf:rest Ncca5d49dca464e539160650d4f677ea3
179 Nc77df353bb2a432e80399f32a6f19a9c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name Cell Cycle
181 rdf:type schema:DefinedTerm
182 Ncca5d49dca464e539160650d4f677ea3 rdf:first sg:person.01043347623.83
183 rdf:rest N6b8de55b36ff4acdb54a038841a78926
184 Nd1cd6d257eb94d7381abbe74b070d411 schema:volumeNumber 92
185 rdf:type schema:PublicationVolume
186 Nd43b82973f014f8e98d0f8b4fab681f9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
187 schema:name Proto-Oncogene Proteins
188 rdf:type schema:DefinedTerm
189 Ne31d1fbde9184fb98a517c8adf97a53d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
190 schema:name Carcinoma, Non-Small-Cell Lung
191 rdf:type schema:DefinedTerm
192 Ne996f74b851746d89c64abcede679406 schema:name doi
193 schema:value 10.1038/sj.bjc.6602382
194 rdf:type schema:PropertyValue
195 Necea93ead5104c8090d2a91f94e5e12b schema:name pubmed_id
196 schema:value 15700043
197 rdf:type schema:PropertyValue
198 Nf00b9452bace4338801d6584e7e50ac8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
199 schema:name Protein-Serine-Threonine Kinases
200 rdf:type schema:DefinedTerm
201 Nf11a68ab250e4255b53c6dd7b8a6c5d6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
202 schema:name Cell Line, Tumor
203 rdf:type schema:DefinedTerm
204 Nf98771973d5c496f886c50b7a83f6326 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
205 schema:name DNA Fragmentation
206 rdf:type schema:DefinedTerm
207 anzsrc-for:06 schema:inDefinedTermSet anzsrc-for:
208 schema:name Biological Sciences
209 rdf:type schema:DefinedTerm
210 anzsrc-for:0601 schema:inDefinedTermSet anzsrc-for:
211 schema:name Biochemistry and Cell Biology
212 rdf:type schema:DefinedTerm
213 sg:journal.1017082 schema:issn 0007-0920
214 1532-1827
215 schema:name British Journal of Cancer
216 rdf:type schema:Periodical
217 sg:person.01003441425.29 schema:affiliation https://www.grid.ac/institutes/grid.5395.a
218 schema:familyName Mey
219 schema:givenName V
220 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01003441425.29
221 rdf:type schema:Person
222 sg:person.0101712630.89 schema:affiliation https://www.grid.ac/institutes/grid.5395.a
223 schema:familyName Del Tacca
224 schema:givenName M
225 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0101712630.89
226 rdf:type schema:Person
227 sg:person.01043347623.83 schema:affiliation https://www.grid.ac/institutes/grid.5395.a
228 schema:familyName Basolo
229 schema:givenName F
230 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01043347623.83
231 rdf:type schema:Person
232 sg:person.01324114222.11 schema:affiliation https://www.grid.ac/institutes/grid.5395.a
233 schema:familyName Barachini
234 schema:givenName S
235 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01324114222.11
236 rdf:type schema:Person
237 sg:person.0577505063.56 schema:affiliation https://www.grid.ac/institutes/grid.5395.a
238 schema:familyName Giovannetti
239 schema:givenName E
240 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0577505063.56
241 rdf:type schema:Person
242 sg:person.0704167507.01 schema:affiliation https://www.grid.ac/institutes/grid.5395.a
243 schema:familyName Danesi
244 schema:givenName R
245 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0704167507.01
246 rdf:type schema:Person
247 sg:pub.10.1007/s002800000183 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000135772
248 https://doi.org/10.1007/s002800000183
249 rdf:type schema:CreativeWork
250 sg:pub.10.1007/s002800000273 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031302839
251 https://doi.org/10.1007/s002800000273
252 rdf:type schema:CreativeWork
253 sg:pub.10.1023/a:1006325929424 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022329366
254 https://doi.org/10.1023/a:1006325929424
255 rdf:type schema:CreativeWork
256 sg:pub.10.1038/sj.bjc.6690452 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004051184
257 https://doi.org/10.1038/sj.bjc.6690452
258 rdf:type schema:CreativeWork
259 sg:pub.10.1038/sj.cdd.4400336 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042512023
260 https://doi.org/10.1038/sj.cdd.4400336
261 rdf:type schema:CreativeWork
262 sg:pub.10.2165/00003495-199754030-00009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011803547
263 https://doi.org/10.2165/00003495-199754030-00009
264 rdf:type schema:CreativeWork
265 https://app.dimensions.ai/details/publication/pub.1074273055 schema:CreativeWork
266 https://app.dimensions.ai/details/publication/pub.1074520995 schema:CreativeWork
267 https://app.dimensions.ai/details/publication/pub.1074708162 schema:CreativeWork
268 https://app.dimensions.ai/details/publication/pub.1074712924 schema:CreativeWork
269 https://app.dimensions.ai/details/publication/pub.1074778809 schema:CreativeWork
270 https://app.dimensions.ai/details/publication/pub.1074859791 schema:CreativeWork
271 https://app.dimensions.ai/details/publication/pub.1075104035 schema:CreativeWork
272 https://app.dimensions.ai/details/publication/pub.1082401402 schema:CreativeWork
273 https://app.dimensions.ai/details/publication/pub.1082893566 schema:CreativeWork
274 https://app.dimensions.ai/details/publication/pub.1083077109 schema:CreativeWork
275 https://app.dimensions.ai/details/publication/pub.1083269732 schema:CreativeWork
276 https://app.dimensions.ai/details/publication/pub.1083347691 schema:CreativeWork
277 https://doi.org/10.1002/(sici)1097-0215(20000515)86:4<570::aid-ijc20>3.0.co;2-t schema:sameAs https://app.dimensions.ai/details/publication/pub.1018134417
278 rdf:type schema:CreativeWork
279 https://doi.org/10.1002/cncr.10806 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014472277
280 rdf:type schema:CreativeWork
281 https://doi.org/10.1002/ijc.10166 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015732358
282 rdf:type schema:CreativeWork
283 https://doi.org/10.1016/s0006-2952(98)00316-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028767356
284 rdf:type schema:CreativeWork
285 https://doi.org/10.1016/s0006-2952(98)00318-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018647627
286 rdf:type schema:CreativeWork
287 https://doi.org/10.1016/s0092-8674(00)81005-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021076197
288 rdf:type schema:CreativeWork
289 https://doi.org/10.1016/s0169-5002(02)00502-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018310648
290 rdf:type schema:CreativeWork
291 https://doi.org/10.1016/s0169-5002(03)00136-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052265808
292 rdf:type schema:CreativeWork
293 https://doi.org/10.1016/s0169-5002(03)90522-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016902652
294 rdf:type schema:CreativeWork
295 https://doi.org/10.1016/s0304-4165(99)00209-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045475119
296 rdf:type schema:CreativeWork
297 https://doi.org/10.1016/s0959-8049(98)00425-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032352964
298 rdf:type schema:CreativeWork
299 https://doi.org/10.1016/s0959-8049(99)00223-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035253746
300 rdf:type schema:CreativeWork
301 https://doi.org/10.1016/s1368-7646(02)00002-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1039632637
302 rdf:type schema:CreativeWork
303 https://doi.org/10.1021/bi9729357 schema:sameAs https://app.dimensions.ai/details/publication/pub.1055215192
304 rdf:type schema:CreativeWork
305 https://doi.org/10.1056/nejmoa031644 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018253348
306 rdf:type schema:CreativeWork
307 https://doi.org/10.1074/jbc.274.7.4335 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016160331
308 rdf:type schema:CreativeWork
309 https://doi.org/10.1081/cnv-120022363 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037383721
310 rdf:type schema:CreativeWork
311 https://doi.org/10.1093/ajhp/54.2.162 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083077109
312 rdf:type schema:CreativeWork
313 https://doi.org/10.1093/jnci/86.20.1517 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007437694
314 rdf:type schema:CreativeWork
315 https://doi.org/10.1093/jnci/88.11.734 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046560733
316 rdf:type schema:CreativeWork
317 https://doi.org/10.1136/bmj.311.7010.899 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062773493
318 rdf:type schema:CreativeWork
319 https://doi.org/10.1158/0008-5472.can-03-3363 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022118795
320 rdf:type schema:CreativeWork
321 https://doi.org/10.1158/1078-0432.ccr-03-0520 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036865675
322 rdf:type schema:CreativeWork
323 https://doi.org/10.1159/000011923 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013350898
324 rdf:type schema:CreativeWork
325 https://doi.org/10.3727/096504001108747819 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074951474
326 rdf:type schema:CreativeWork
327 https://www.grid.ac/institutes/grid.5395.a schema:alternateName University of Pisa
328 schema:name Division of Pathological Anatomy and Histology, Department of Oncology, Transplants and Advanced Technologies in Medicine, University of Pisa, Pisa, Italy
329 Division of Pharmacology and Chemotherapy, Department of Oncology, Transplants and Advanced Technologies in Medicine, University of Pisa, 55, Via Roma, 56126 Pisa, Italy
330 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...